• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Certara, Inc. - Common Stock (NQ:CERT)

5.840 +0.350 (+6.38%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Certara, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Bragar Eagel & Squire, P.C. is Investigating Certara, Inc. on Behalf of Certara Stockholders and Encourages Investors to Contact the Firm
June 19, 2026
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Certara Announces CFO Transition
June 17, 2026
Reaffirms 2026 Guidance 
From Certara
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Certara, Inc. - CERT
June 09, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
Certara Outlines AI Push, Cost Cuts and New Growth Engines at Jefferies Conference ↗
June 07, 2026
Certara (NASDAQ:CERT) executives outlined the company’s strategic realignment, artificial intelligence initiatives and cost priorities during a discussion at Jefferies’ 2026 Global Healthcare... 
Via MarketBeat
Topics Artificial Intelligence
Certara (NASDAQ:CERT) Q1 2026: Software Shines, but Divestiture and Mixed Metrics Weigh on Shares ↗
May 11, 2026
Via Chartmill
Certara Inc (NASDAQ:CERT) Reports Mixed Q4 2025 Results and Cautious 2026 Outlook ↗
February 26, 2026
Via Chartmill
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Certara, Inc. - CERT
June 02, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Certara, Inc. - CERT
May 26, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
CERT Investors Have Opportunity to Join Certara, Inc. Fraud Investigation with the Schall Law Firm
May 24, 2026
From Schall Law
Via GlobeNewswire
News headline image
CERT SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
May 22, 2026
From Kirby McInerney LLP
Via GlobeNewswire
News headline image
CERT SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
May 20, 2026
From Kirby McInerney LLP
Via Business Wire
News headline image
CERT SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
May 18, 2026
From Kirby McInerney LLP
Via GlobeNewswire
News headline image
Certara to Participate in Upcoming Investor Conferences
May 18, 2026
From Certara
Via GlobeNewswire
News headline image
CERTARA INVESTOR ALERT: Bragar Eagel & Squire, P.C. is Investigating Certara, Inc. on Behalf of Certara Stockholders and Encourages Investors to Contact the Firm
May 15, 2026
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
CERTARA, INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud
May 13, 2026
From Kirby McInerney LLP
Via Business Wire
News headline image
Certara (CERT) Q1 2026 Earnings Call Transcript ↗
May 11, 2026
Certara (CERT) Q1 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Artificial Intelligence Earnings
News headline image
Certara Q1 Earnings Call Highlights ↗
May 11, 2026
Certara (NASDAQ:CERT) reported first-quarter 2026 revenue of $106.9 million, up 1% from the prior-year period, as stronger software performance offset softer services results and the company outlined a... 
Via MarketBeat
Topics Earnings
News headline image
Certara Reports First Quarter 2026 Financial Results
May 11, 2026
Updates 2026 Guidance to reflect completed divestiture of Regulatory Writing and Medical Writing Business 
From Certara
Via GlobeNewswire
News headline image
Altasciences and Certara Announce Strategic Partnership to Accelerate Early Drug Development
May 07, 2026
From Altasciences
Via Business Wire
News headline image
Certara Enters Definitive Agreement for the Sale of its Regulatory and Medical Writing Business to Veristat
April 22, 2026
From Certara
Via GlobeNewswire
News headline image
Certara to Report First Quarter 2026 Financial Results on May 11th, 2026
April 09, 2026
From Certara
Via GlobeNewswire
News headline image
Certara Simcyp® Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib
March 03, 2026
Biosimulation results highlight how model-informed approaches for drug development and regulatory decision-making save time and money. 
From Certara
Via GlobeNewswire
News headline image
Certara to Participate in Upcoming Investor Conferences
February 27, 2026
From Certara
Via GlobeNewswire
News headline image
Certara Reports Fourth Quarter 2025 Financial Results; Provides Full Year 2026 Guidance
February 26, 2026
From Certara
Via GlobeNewswire
News headline image
Certara to Report Fourth Quarter and Full Year 2025 Financial Results on February 26th, 2025
January 29, 2026
From Certara
Via GlobeNewswire
News headline image
Certara’s Volatility: From a 23% Earnings Plunge to a $3 Million Institutional Vote of Confidence
January 05, 2026
The biosimulation market was sent into a tailspin in the closing months of 2025 as Certara (Nasdaq:CERT), a global leader in model-informed drug development, saw its market valuation crater by 23%. The... 
Via MarketMinute
Topics Earnings
News headline image
Certara Stock Fell 23% After Earnings and This Fund Bought Up $3 Million Anyway ↗
January 05, 2026
Certara provides biosimulation software and regulatory solutions to global biopharma clients, supporting drug development and approvals. 
Via The Motley Fool
News headline image
Certara Appoints Jon Resnick as Chief Executive Officer
December 11, 2025
From Certara
Via GlobeNewswire
News headline image
Healthcare AI Exits Pilot Phase, Enters Production Deployment
December 12, 2025
Issued on behalf of VentriPoint Diagnostics Ltd. 
From Equity Insider
Via GlobeNewswire
News headline image
ArrowMark Slashes Alight Position Amid Growing Questions About Its Recurring-Revenue Strategy ↗
December 04, 2025
ArrowMark’s sharp reduction in its Alight stake comes at a moment when the market is questioning whether the company can turn its consulting-heavy work into steadier recurring revenue, and that tension... 
Via The Motley Fool
Topics Regulatory Compliance
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap